ReShape Lifesciences™ Receives FDA 510(k) Clearance for the GIBI HD™ Calibration Tubes for use in Gastric and Bariatric Procedures
August 10, 2022 12:05 ET
|
ReShape Lifesciences Inc
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at...
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
July 27, 2022 16:05 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its...
ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds
June 17, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that...
ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™
May 26, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif. and DES MOINES, Iowa, May 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company and...
ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 23, 2022 08:00 ET
|
ReShape Lifesciences Inc
March 2022 Revenues Exceeded January’s and February’s, Combined, Indicating DTC Campaign and Other Visibility Activities are Driving Significant Demand for Lap-Band® Procedures Conference Call to be...
ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards
May 19, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Vernon...
ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
May 16, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...
ReShape Lifesciences to Present at the Q2 Investor Summit
April 26, 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Bart...
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
March 28, 2022 16:05 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported...
ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band®
March 24, 2022 08:30 ET
|
ReShape Lifesciences Inc
New Generation of Patients are Engaged as Evidenced by Surge in Website Traffic and Doctor Referrals Bariatric Surgeons Seeing Increases in Patient Consultations and Procedures Insurance...